Halozyme Therapeutics reported $40.24M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amarin AMRN:US 155.11M 9.4M
Amgen AMGN:US $ 4.33B 1.37B
Aptinyx Inc APTX:US $ 21.21M 1.34M
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Baxter International BAX:US $ 2731M 57M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Cytokinetics CYTK:US $ 74.64M 17M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Esperion Therapeutics ESPR:US $ 70.15M 3.04M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Immunogen IMGN:US $ 43.44M 873K
Intercept Pharmaceuticals ICPT:US $ 82.54M 13.28M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
Intrexon XON:US $ 47.03M 2.22M
JAZZ PHA JAZZ:US $ 809.75M 11.66M
Mannkind MNKD:US $ 23.87M 31.81M
Minerva Neurosciences NERV:US $ 7.52M 1.45M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Peregrine Pharmaceuticals PPHM:US $ 23.82M 695K
Pfizer PFE:US $ 16447M 3384M
Rigel Pharmaceuticals RIGL:US $ 41.33M 2.01M
United Therapeutics UTHR:US $ 216M 10.6M
Vanda Pharmaceuticals VNDA:US $ 59.28M 3.75M